Cargando…
Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG
HeberFERON, a co-formulation of Interferon (IFN)-α2b and IFN-γ, has effects on skin cancer and other solid tumors. It has antiproliferative effects over glioblastoma multiform (GBM) clones and cultured cell lines, including U-87 MG. Here, we report the first label-free quantitative proteomic and pho...
Autores principales: | Vázquez-Blomquist, Dania, Hardy-Sosa, Anette, Baez, Saiyet C., Besada, Vladimir, Palomares, Sucel, Guirola, Osmany, Ramos, Yassel, Wiśniewski, Jacek R., González, Luis Javier, Bello-Rivero, Iraldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776974/ https://www.ncbi.nlm.nih.gov/pubmed/36552831 http://dx.doi.org/10.3390/cells11244068 |
Ejemplares similares
-
Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells
por: Núñez de Villavicencio-Díaz, Teresa, et al.
Publicado: (2015) -
Reginald Heber Fitz, The Exponent of Appendicitis
por: Loveland, John E.
Publicado: (1937) -
In Memoriam—Dr. J. Heber Smith
Publicado: (1898) -
Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945
por: Rosales, Mauro, et al.
Publicado: (2021) -
A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG
por: Miranda, Jamilet, et al.
Publicado: (2023)